Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation

Clinical Cancer Research

Volumn 9, Issue 7, 2003, Pages 2866-2875

  Tan, YingMeei ^a   Yu, Rong ^a,b   Pezzuto, John M ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIOXIDANT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BETULIC ACID; CASPASE; CASPASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MELANOMA CELL; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; INTRACELLULAR MEMBRANES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MELANOMA; MEMBRANE POTENTIALS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; TIME FACTORS; TRITERPENES;

EID: 0038492656     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Pisha, E., Chai, H., Lee, I. S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W., Fong, H. H., Kinghorn, A. D., Brown, D. M., Wani, M. C., Wall, M. E., Hieken, T. J., Das Gupta, T. K., and Pezzuto, J. M. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med., 1: 1046-1051, 1995.
2. O'Connell, M., Bently, M., Campbell, C., and Cole, B. Betulin and lupeol in bark from four white-barked birches. Phytochemistry, 27: 2175-2176, 1998.
3. Kim, D., Chen, Z., Nyugen, T., Pezzuto, J. M., Qiu, S., and Lu, Z-Z. A concise semi-synthetic approach to betulinic acid from betulin. Synthet. Commun., 27: 1607-1612, 1997.
4. Schmidt, M. L., Kuzmanoff, K. L., Ling-Indeck, L., and Pezzuto, J. M. Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur. J. Cancer, 33: 2007-2010, 1997.
5. Fulda, S., Jeremias, I., Steiner, H., Pietsch, T., and Debatin, K-M. Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells. Int. J. Cancer, 82: 435-441, 1999.
6. Wick, W., Grimmel, C., Wagenknecht, B., Dichgans, J., and Weller, M. Betulinic acid-induced apoptosis in glioma cells: a sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J. Pharmacol. Exp. Ther., 289: 1306-1312, 1999.
7. Noda, Y., Kaiya, T., Kohda, K., and Kawazoe, Y. Enhanced cytotoxicity of some triterpenes toward leukemia L1210 cells cultured in low pH media: possibility of a new mode of cell killing. Chem. Pharm. Bull., 45: 1665-1670, 1997.
8. Pezzuto, J. M., Das Gupta, T. K., Schmidt, M. L., Kuzmanoff, K., Ling-Indeck, L., and Kim, D. Method and composition for treating cancers. US Patent 5, 962, 527. USA: The Board of Trustees of the University of Illinois, 1999.
9. Fulda. S., Scaffidi, C., Susin. S. A., Krammer. P. H., Kroemer, G., Peter, M. E., and Debatin, K. M. Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem., 273: 33942-33948, 1998.
10. Chang, L., and Karin, M. Mammalian MAP kinase signaling cascades. Nature (Lond.), 410: 37-40, 2001.
11. Xia, Z., Dickens, M., Raingeaud, J., Davis, R., and Greenberg, M. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Wash. DC), 270: 1326-1331, 1995.
12. Pezzuto, J., Shieh, H., Shaughnessy, E., and Beattie. C. Approaches for drug development in treatment of advanced melanoma. Semin. Oncol., 15, 578-588. 1988.
13. Slater, A., Nobel, S., and Orrenius, S. The role of intracellular oxidants in apoptosis. Biochim. Biophys. Acta, 1271: 59-62. 1995.
14. Cryns, V., and Yuan, J. The cutting edge: Caspases in apoptosis and disease. In: R. Lockshin, Z. Zakeri, and J. Tilly (eds.). When Cells Die, pp. 177-210. New York: Wiley-Liss, Inc., 1998.
15. Ip, Y., and Davis, R. Signal transduction by the c-Jun-N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol., 10: 205-219, 1998.
16. Ono, K., and Han, J. The p38 signal transduction pathway: activation and function. Cell. Signal., 12: 1-13, 2000.
17. Fulda, S., Susin, S., Kroemer, G., and Debatin, K. Molecular ordering of drug-induced apoptosis in neuroblastoma cells. Cancer Res., 58: 4453-4460, 1998.
18. Kluck, R., Martin, S., Hoffman, B., Zhou, J., Green, D., and Newmeyer, D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Wash. DC), 275: 1132-1136, 1997.
19. Li, P., Nijhawan, D., Budihardoj, I., Srinivasla, S., Ahman, M., Alnemri, E., and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91: 479-489, 1997.
20. Zou, H., Henzel, W., Liu, X., Lutschg, A., and Wang, X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome-c dependent activation of caspase-3. Cell, 90: 405-413, 1997.
21. Zamzami, N., Marchetti, P., Castedo, M., T, H., Susin, S., Masse, B., and Kroemer, G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial membrane potential during apoptosis. FEBS Lett., 384: 153-157, 1996.
22. Zamzami, N., Susin, S., Marchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M., and Kroemer, G. Mitochondrial control of apoptosis. J. Exp. Med., 183: 1533-1544, 1996.
23. Green, D., and Beere, H. Killers or Clean-up Crew: How central are the central mechanisms of apoptosis. In: J. Hickman and C. Dive (eds.), Apoptosis and Cancer Chemotherapy, pp. 157-174. New Jersey: Humana Press Inc., 1999.
24. Brenner, C., and Kroemer. G. Mitochondria-the death signal integrators. Science (Wash. DC), 289: 1150-1151, 2000.
25. Joza, N., Kroemer, G., and Penniger, J. Genetic analysis of the mammalian cell death machinery. Trends Genet., 18: 142-149, 2002.
26. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S. A., Petit, P. X., Mignotte, B., and Kroemer, G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med., 182: 367-377, 1995.
27. Pervaiz, S., and Clement, M-V. A permissive apoptotic environment: Function of a decrease in intracellular superoxide anion and cytosolic acidification. Biochem. Biophys. Res. Comm., 290: 1145-1150, 2002.
28. Tan, S., Sagara, Y., Liu, Y., Maher, P., and Schubert, D. The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol., 141: 1423-1432, 1998.
29. Kamata, H., and Hirata, H. Redox regulation of cellular signaling. Cell. Signal., 11, 1-14, 1999.
30. Yu, R., Tan, T-H., and Kong, A-N. Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases: the role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J. Biol. Chem., 272: 28962-28970, 1997.
31. Ichijo, H. From receptors to stress-activated MAP kinases. Oncogene, 18: 6087-6093, 1999.
32. Davis, R. Signal transduction by the JNK group of MAP kinases. Cell, 103: 239-252, 2000.
33. Zhuang, S., Demirs, J., and Kochevar, I. p38 Mitogen-activated protein kinase mediates Bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by single oxygen but not by hydrogen peroxide. J. Biol. Chem. 275: 25939-15948, 2000.
34. Hengartner, M. The biochemistry of apoptosis. Nature (Lond.), 407: 770-776, 2000.
35. Miyazaki, K., Yoshida, H., Sasaki, M., Hara, H., Kimura, G., Mak, T., and Nomoto, K. Caspase-independent cell death and mitochondrial disruptions observed in the Apaf-1-deficient cells. J. Biochem., 129: 963-969, 2001.
36. Mathiasen, I. S., and Jaattela, M. Triggering caspase-independent cell death to combat cancer. Trends Mol. Med., 8: 212-220, 2002.
37. Leist, M., and Jaattela, M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol., 2: 589-598, 2001.
38. Xiang, J., Chao, D., and Kormeyer, S. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA, 93: 14559-14563, 1996.
39. Susin, S., Lorenzo, H., Zamzami, N., Marzo, I., Snow, B., Brothers, G., Mangion, J., Jacotot, E., Constantini, P., Goodlett, D., Aebersold, R., Siderovski, D., Penninger, J., and Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (London), 397: 441-446, 1999.
40. Garrido, C., Gurbuxani, S., Ravagnan, L., and Kroemer, G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun., 286: 433-442, 2001.
41. Hegde, R., Srinivasula, S., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A., Fernandes-Alnemri, T., and Alnemri, E. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem., 277, 432-438, 2002.
42. Verhagen, A., Silke, J., Ekert, P., Pakusch, M., Kaufmann, H., Connolly, R., Day, C., Tikoo, A., Burke, R., Wrobel, C., Moritz, R., Simpson, R., and Vaux, D. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J, Biol. Chem., 277: 445-454, 2002.
43. Green, D., and Evan, G. A matter of life and death. Cancer Cell., 1: 19-30, 2002.